• LAST PRICE
    1.0700
  • TODAY'S CHANGE (%)
    Trending Up0.0700 (7.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    1.0700 / 1.0000
  • Day Range
    Low 1.0700
    High 1.0700
  • 52 Week Range
    Low 0.6601
    High 5.3500
  • Volume
    1,054
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.07
TimeVolumeIMUN
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMUN
Immune Therapeutics Inc
82.8M
-0.2x
---
United StatesENLV
Enlivex Therapeutics Ltd
82.8M
-3.2x
---
United StatesENOB
Enochian Biosciences Inc
81.5M
-1.9x
---
United StatesINKT
Mink Therapeutics Inc
84.5M
-3.4x
---
United StatesMYMD
MyMD Pharmaceuticals Inc
80.5M
-5.6x
---
United StatesIOBT
IO Biotech Inc
87.0M
-1.2x
---
As of 2022-11-30

Company Information

Immune Therapeutics, Inc. is a drug development and commercialization company. The Company identifies, evaluates and seeks to acquire technologies in the medical device and drug development sectors. The Company executed two licenses, which are Cytocom, Inc. (Cytocom) and Forte Animal Health, Inc. (Forte). The Company's products are used in veterinary applications for all indications.

Contact Information

Headquarters
2431 Aloma Ave #124WINTER PARK, FL, United States 32792
Phone
407-680-3097
Fax
407-641-8668

Executives

Independent Chairman of the Board
Roscoe Moore
Interim President, Interim Chief Executive Officer, Chief Operating Officer
Kelly Wilson
Chief Financial Officer
Glen Farmer
Director
H. Louis Salomonsky
Director
Robert Wilson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$82.8M
Revenue (TTM)
$0.00
Shares Outstanding
82.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.85
EPS
$-5.52
Book Value
$-16.43
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.